Public Health

The Deadliest Wildfire in Modern US History Is Teaching Us That the Fire Is Only Half the Harm

Nearly three years after flames destroyed Lāhainā and killed more than 100 people, the most striking finding from the study tracking survivors is not about smoke or burns. It is that much of the lasting damage came from what happened after the fire went out, from losing homes and jobs, and that this harm reached people who never lived near the flames.

That result is changing how researchers think about what disaster recovery actually needs to do.

What the study is

Once a month, University of Hawaiʻi researchers fly medical equipment from Oʻahu to west Maui and turn a local health center into a temporary lab, collecting blood, urine, DNA, lung function, and mental health measures from wildfire survivors. The Maui Wildfire Exposure Study, MauiWES, is one of the largest and most comprehensive postfire investigations in the country, designed to follow participants for a decade or more to see whether they develop cancers, lung disease, and other conditions linked to fire exposure.

What makes it scientifically valuable is who it enrolls. It is the largest and most ethnically diverse longitudinal cohort in any US postfire study, including Native Hawaiian, Pacific Islander, Hispanic, Filipino, Asian, and white residents, with 91% of participants having lived or worked in Lāhainā during the fire. That diversity matters because most of what is known about disaster health comes from less representative populations, and the communities hit hardest here were already facing health disparities and limited access to care before the fire.

The finding that reframes everything

The headline result, published in JAMA Psychiatry, is counterintuitive enough to change practice. The fires triggered an island-wide mental health crisis, and more than half of the disaster's impact on depression and anxiety could be traced to increased housing and job insecurity rather than to the trauma of the fire itself.

The numbers make the point precisely. People inside the burn zones had a 53% higher risk of depression and a 67% higher risk of anxiety. But for wildfire survivors, housing and job insecurity explained nearly 62% of the depressive symptoms and 77% of the anxiety symptoms the disaster caused. And the harm did not respect the edge of the burn zone. Maui residents who lived outside the fire areas also showed significantly elevated risks, including more than double the risk of suicidal thoughts.

Sit with what that means. The thing most damaging to mental health was not proximity to the flames. It was losing your home and your income, which can happen to someone whose house never burned, in a place where the fire destroyed so much housing and economic activity that the disruption rippled across the whole island. As the study's lead author put it, housing displacement and income loss were not side issues but central drivers of psychological harm.

One corollary from the same data points straight at a solution: being employed was strongly protective against depression, anxiety, and suicidal thoughts. That is not a soft observation. It says that economic recovery is mental health treatment, that getting people back into stable housing and work does clinical good that is otherwise hard to achieve.

Why this changes the recovery playbook

The conventional model of disaster response treats the acute event as the emergency: put out the fire, treat the injured, provide short-term shelter, then wind down as the crisis passes. This study is evidence that the model ends too early and aims at the wrong target.

If most of the lasting psychological harm flows from housing and job loss, then the recovery that actually protects health is not measured in weeks of emergency response. It is measured in how fast people get back into permanent homes and stable work, which in Lāhainā has been painfully slow, with fewer than 300 homes rebuilt as of this summer against thousands destroyed and roughly 10,000 people displaced. Every month of delayed rebuilding is not just a housing problem. On this evidence, it is an active mental health harm, prolonging the exposure that drives the depression and anxiety.

That reframing has a practical edge. It means the agencies responsible for housing, permitting, and economic recovery are, functionally, mental health agencies after a disaster, whether or not anyone describes them that way. And it means a recovery judged successful on physical rebuilding metrics can still be failing on the measure that matters most to survivors, if it leaves people in limbo for years.

The physical health signals are real too

The mental health findings are the most developed, but the study is also tracking bodies, and the early readings warrant the long timeline. Among adults enrolled six to 14 months after the fires, 22% showed reduced lung function and 50% screened positive for depressive symptoms. Later reporting from the study found more than 40% of adults reporting worsening health, nearly 75% with elevated blood pressure, and more than a quarter with worsening lung function, alongside more than half of children aged 8 to 18 screening positive for depression.

These are screening findings from an exposed cohort, not proof that the fire caused each condition, and the study is careful about that distinction, which is exactly why it is designed to run for a decade or two. Urban wildfires like Lāhainā burn homes, cars, plastics, and industrial materials, producing a chemical mix quite different from a forest fire, and the long-term consequences of breathing that are genuinely not well understood. The value of following the same people for years is that it can separate lasting effects from transient ones in a way a snapshot never could.

The part that makes this fragile

There is a hard irony in the timing. This study exists to show that long-term support matters, and its own long-term funding is uncertain. Hawaiʻi cut state funding for the study earlier this year, with a $3 million request described as crucial to continue screenings, return results, provide referrals, and expand care to a waitlist that includes 1,000 children. NIH has renewed a portion of the funding, but the gap between what the study needs and what it has is real.

That threatens something beyond the research. For many participants, MauiWES is not only a study; it is a source of actual screening and referral in a community with limited access to care, the mechanism by which someone learns their lung function has declined or their blood pressure is dangerous. Defunding it removes both the knowledge and, for some, the care.

A study researcher drew a comparison worth taking seriously, to September 11, where in the years afterward more people died from illnesses linked to the exposure than in the attack itself, and where a long-term health program eventually became essential precisely because the delayed harms were not visible at first. The parallel is a warning: the costs that show up later are easy to underfund now, exactly because they have not shown up yet. Investing in prevention and monitoring is cheaper than treating the crises that arrive when no one was watching, but only if the monitoring survives long enough to do its job.

Lāhainā is teaching a lesson that applies well beyond Maui, as wildfires grow more frequent and more likely to reach towns rather than just wildland. The fire is the visible disaster. The invisible one is the slow grind of displacement, lost income, and prolonged instability, and on this evidence that second disaster does more lasting damage to mental health than the first. The most important finding of the largest postfire study in the country is almost administrative in its plainness: what you do in the years after the fire matters as much as the fire, and the recovery is not over when the emergency ends. It is over when people are home.

If you or someone you know is struggling in the aftermath of a disaster or experiencing thoughts of suicide, support is available. In the US, the 988 Suicide and Crisis Lifeline can be reached by calling or texting 988.

Further reading

Written by James T.

Do you disagree with any of the medical statements in this article? Email [email protected] with your feedback.

This is general information about a research study and disaster recovery, not medical or mental health advice. Screening findings from a study cohort do not establish causation for any individual. Anyone concerned about their physical or mental health after a disaster should consult a qualified clinician. Sources: STAT, Honolulu Civil Beat, Science/AAAS, JAMA Network Open, and AsAmNews. Mavengity is editorially independent.
Keep reading

More from Healthcare & Medical

growth disorders

A Growth Drug Passed Its Pivotal Test in a Second Bone Condition

Detailed Phase III results for Voxzogo in hypochondroplasia showed a 2.33 centimeter annual growth velocity advantage, published in NEJM Evidence.

By James T.·September 9, 2026·7 min read
angioedema

An Oral Drug Cut HAE Attacks by 83 Percent in a Pivotal Trial

Pharvaris' deucrictibant extended-release tablets met the primary endpoint of the CHAPTER-3 study, including in the HAE subgroup with no dedicated prophylactic option.

By James T.·September 9, 2026·7 min read
lung cancer

The First Survival Win for a BiTE Drug Arrives in Small Cell Lung Cancer

AstraZeneca and Amgen's DeLLphi-305 trial showed Imfinzi plus Imdelltra improved overall survival in extensive-stage small cell lung cancer.

By James T.·September 9, 2026·7 min read
rare disease

The $12 Billion Muscle Drug Missed Its Big Test

Novartis' del-desiran failed its Phase III endpoint in myotonic dystrophy type 1, a setback for the centerpiece of the Avidity Biosciences acquisition.

By James T.·September 9, 2026·7 min read
Drug Development

Europe's Biotech Act Promises Faster Trials the EU Has Never Managed

The European Commission wants clinical trial authorization cut from about 106 days to 75. The EU's first progress report on its 2030 trial targets shows why the Act exists: the continent's trial machine is running behind its own goals.

By James T.·September 8, 2026·8 min read
Mental Health

California Draws the Line Between an AI Assistant and a Therapist

California's pending SB 903 would ban unlicensed AI therapy and restrict how licensed professionals use AI with patients. The bill's principle is that what matters is the conduct, not what the app calls itself.

By James T.·September 8, 2026·8 min read
Data Privacy

One Compromised Account Cost a French Hospital 727,000 Patient Records

France's data regulator fined a Saint-Étienne private hospital €500,000 after an attacker used a single doctor's account to drain its patient record system, and the findings read like a checklist the sector has ignored for years.

By James T.·7 min read
Clinical Trials

The Lp(a) Hypothesis Just Lost Its First Big Test

Novartis reported that pelacarsen failed its cardiovascular outcomes trial, the first major test of whether lowering lipoprotein(a) prevents heart attacks and strokes. The class is not dead, but the theory now needs a new proof.

By James T.·8 min read
Public Health

Iowa's Opioid Settlement Money Moved. The First $1.6 Million Shows Where

The state's first wave of opioid settlement grants funds jail re-entry, peer support, a homeless shelter, youth prevention and a drug incinerator, and the list is a map of how Iowa intends to spend $365 million.

By James T.·7 min read